GEN1 小时
Checkpoint Inhibitors May Be Improved by Metabolic Reprogramming of T Cells
Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...
Metabolic reprogramming of T cells may enhance checkpoint inhibitor therapy
Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...
Mena FN5 天
DELTAREX-G FOR CAR-T CELL THERAPY INDUCED CYTOKINE RELEASE SYNDROME
Haroun stated“This theory is supported by the inhibitory activity of DeltaRex-G in transduced CD4+ CD8+ cell cultures. DeltaRex-G may be used to treat CRS by inhibiting a certain proportion of the ...
Targeted Oncology6 天
Lunning Evaluates CAR T-Cell Therapy for ASCT-Eligible and Ineligible DLBCL
During a Case-Based Roundtable® event, Matthew A. Lunning, DO, discussed the updated trial data for 2 chimeric antigen ...